{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:37:13Z","timestamp":1790883433878,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"vor","delay-in-days":37,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jcf.2019.08.016","type":"journal-article","created":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T04:54:04Z","timestamp":1572756844000},"page":"S3-S9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":162,"special_numbering":"S2","title":["Cystic fibrosis related diabetes: Pathophysiology, screening and diagnosis"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2124-6267","authenticated-orcid":false,"given":"Andrea","family":"Granados","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3067-7672","authenticated-orcid":false,"given":"Christine L.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie Larson","family":"Ode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9909-6724","authenticated-orcid":false,"given":"Amir","family":"Moheet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Holl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2019.08.016_bb0005","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.2337\/dc10-1279","article-title":"Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcf.2019.08.016_bb0010","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1164\/rccm.201403-0576OC","article-title":"Diabetes-related mortality in adults with cystic fibrosis. Role of genotype and sex","volume":"191","author":"Lewis","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.jcf.2019.08.016_bb0015","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2337\/dc09-0585","article-title":"Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.016_bb0020","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1399-5448.2008.00451.x","article-title":"One-year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements","volume":"10","author":"Mozzillo","year":"2009","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jcf.2019.08.016_bb0025","doi-asserted-by":"crossref","DOI":"10.2337\/dc09-0586","article-title":"Cystic fibrosis\u2013related diabetes: current trends in prevalence, incidence, and mortality","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.016_bb0030","first-page":"342","article-title":"Islet hormone and Incretin secretion in cystic fibrosis following 4-months of Ivacaftor therapy","volume":"199","author":"Kelly","year":"2018","journal-title":"AJRCCM"},{"issue":"10","key":"10.1016\/j.jcf.2019.08.016_bb0035","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.2337\/db13-0510","article-title":"Genetic modifiers of cystic fibrosis-related diabetes","volume":"62","author":"Blackman","year":"2013","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.jcf.2019.08.016_bb0040","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1007\/s00125-009-1436-2","article-title":"A susceptibility gene for type 2 diabetes confers substantial risk for diabetes complicating cystic fibrosis","volume":"52","author":"Blackman","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcf.2019.08.016_bb0045","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jpeds.2004.12.039","article-title":"Epidemiology of cystic fibrosis-related diabetes","volume":"146","author":"Marshall","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2019.08.016_bb0050","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.2337\/dc08-0466","article-title":"Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adults","volume":"31","author":"Adler","year":"2008","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.jcf.2019.08.016_bb0055","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1445-5994.2008.01786.x","article-title":"Prior diabetes mellitus is associated with increased morbidity in cystic fibrosis patients undergoing bilateral lung transplantation: an \u201corphan\u201d area? A retrospective case-control study","volume":"39","author":"Bradbury","year":"2009","journal-title":"Intern Med J"},{"issue":"8","key":"10.1016\/j.jcf.2019.08.016_bb0060","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1164\/rccm.201512-2518OC","article-title":"Abnormal glucose tolerance in infants and young children with cystic fibrosis","volume":"194","author":"Yi","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.jcf.2019.08.016_bb0065","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1399-5448.2009.00632.x","article-title":"Oral glucose tolerance testing in children with cystic fibrosis Ode et al","volume":"11","author":"Ode","year":"2010","journal-title":"Pediatr Diabetes"},{"issue":"Suppl 1","key":"10.1016\/j.jcf.2019.08.016_bb0070","first-page":"S13","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.jcf.2019.08.016_bb0075","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.2337\/dc11-2327","article-title":"No relation between cystic fibrosis-related diabetes and type 1 diabetes autoimmunity","volume":"35","author":"Gottlieb","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcf.2019.08.016_bb0080","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1651-2227.1993.tb12653.x","article-title":"Longitudinal evaluation of glucose tolerance and insulin secretion in non-diabetic children and adolescents with cystic fibrosis: results of a two-year follow-up","volume":"82","author":"Arrigo","year":"1993","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jcf.2019.08.016_bb0085","doi-asserted-by":"crossref","first-page":"1527932","DOI":"10.1155\/2016\/1527932","article-title":"Glucose >200mg\/dL during continuous glucose monitoring identifies adult patients at risk for development of cystic fibrosis related diabetes","volume":"2016","author":"Taylor-Cousar","year":"2016","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.jcf.2019.08.016_bb0090","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jcf.2013.02.008","article-title":"Update on cystic fibrosis-related diabetes","volume":"12","author":"Kelly","year":"2013","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2019.08.016_bb0095","doi-asserted-by":"crossref","first-page":"17231","DOI":"10.1038\/s41598-017-17404-z","article-title":"Structural abnormalities in islets from very young children with cystic fibrosis may contribute to cystic fibrosis-related diabetes","volume":"7","author":"Bogdani","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcf.2019.08.016_bb0100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/15513818609025923","article-title":"Pancreatic islets in older patients with cystic fibrosis with and without diabetes mellitus: morphometric and immunocytologic studies","volume":"6","author":"Soejima","year":"1986","journal-title":"Pediatr Pathol"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.016_bb0105","first-page":"1267","article-title":"Diabetes mellitus in cystic fibrosis is characterized by islet amyloidosis","volume":"81","author":"Couce","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcf.2019.08.016_bb0110","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S0022-3476(97)70282-8","article-title":"Insulin resistance is associated with decreased clinical status in cystic fibrosis","volume":"130","author":"Hardin","year":"1997","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2019.08.016_bb0115","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1741-7015-12-87","article-title":"CFTR and Anoctamin 1 (ANO1) contribute to cAMP amplified exocytosis and insulin secretion in human and murine pancreatic beta-cells","volume":"12","author":"Edlund","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.jcf.2019.08.016_bb0120","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1038\/ncomms5420","article-title":"Glucose-induced electrical activities and insulin secretion in pancreatic islet \u03b2-cells are modulated by CFTR","volume":"5","author":"Guo","year":"2014","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.016_bb0125","doi-asserted-by":"crossref","first-page":"E200","DOI":"10.1152\/ajpendo.00333.2015","article-title":"CFTR silencing in pancreatic \u03b2-cells reveals a functional impact on glucose-stimulated insulin secretion and oxidative stress response","volume":"310","author":"Ntimbane","year":"2016","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jcf.2019.08.016_bb0130","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98240","article-title":"Cystic fibrosis\u2013related diabetes is caused by islet loss and inflammation","volume":"3","author":"Hart","year":"2018","journal-title":"JCI Insight"},{"issue":"10","key":"10.1016\/j.jcf.2019.08.016_bb0135","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1210\/en.2017-00187","article-title":"CFTR influences beta cell function and insulin secretion through non-cell autonomous exocrine-derived factors","volume":"158","author":"Sun","year":"2017","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.016_bb0140","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jcf.2017.11.016","article-title":"Effect of Lumacaftor\/Ivacaftor on glucose metabolism and insulin secretion in Phe508del homozygous cystic fibrosis patients","volume":"17","author":"Thomassen","year":"2018","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2019.08.016_bb0145","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jcf.2018.07.010","article-title":"Continuous glucose monitoring in youth with cystic fibrosis treated with lumacaftor-ivacaftor","volume":"18","author":"Li","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2019.08.016_bb0150","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41598-017-00098-8","article-title":"CFTR is involved in the regulation of glucagon secretion in human and rodent alpha cells","volume":"7","author":"Edlund","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcf.2019.08.016_bb0155","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0022-3476(05)80032-0","article-title":"Pancreatic endocrine function in cystic fibrosis","volume":"118","author":"Moran","year":"1991","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.jcf.2019.08.016_bb0160","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.2337\/diabetes.50.6.1336","article-title":"Protein metabolism in clinically stable adult cystic fibrosis patients with abnormal glucose tolerance","volume":"50","author":"Moran","year":"2001","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.016_bb0165","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1042\/CS20140059","article-title":"Glycaemic regulation and insulin secretion are abnormal in cystic fibrosis pigs despite sparing of islet cell mass","volume":"128","author":"Uc","year":"2015","journal-title":"Clin Sci"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.016_bb0170","first-page":"207","article-title":"Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients withnormal, impaired, and diabetic glucose tolerance","volume":"128","author":"Lanng","year":"1993","journal-title":"Acta Endocrinol"},{"issue":"4","key":"10.1016\/j.jcf.2019.08.016_bb0175","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2337\/dc17-1387","article-title":"Islet interleukin-1\u03b2 immunoreactivity is an early feature of cystic fibrosis that may contribute to \u03b2-cell failure","volume":"41","author":"Hull","year":"2018","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.016_bb0180","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2337\/diabetes.48.3.491","article-title":"The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles","volume":"48","author":"Janson","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.jcf.2019.08.016_bb0185","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1210\/js.2018-00143","article-title":"An increase in chromogranin A-positive, hormone-negative endocrine cells in pancreas in cystic fibrosis","volume":"2","author":"Cory","year":"2018","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.jcf.2019.08.016_bb0190","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.2337\/diabetes.48.5.1082","article-title":"Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis","volume":"48","author":"Hardin","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.jcf.2019.08.016_bb0195","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2265.1994.tb02533.x","article-title":"Insulin sensitivity and insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance","volume":"41","author":"Lanng","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jcf.2019.08.016_bb0200","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2310\/JIM.0b013e3181671788","article-title":"Elevated gluconeogenesis and lack of suppression by insulin contribute to cystic fibrosis-related diabetes","volume":"56","author":"Hardin","year":"2008","journal-title":"J Invest Med"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.016_bb0205","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1210\/jcem-69-2-317","article-title":"Severity, duration, and mechanisms of insulin resistance during acute infections","volume":"69","author":"Yki-J\u00e4rvinen","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.016_bb0210","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1203\/00006450-199308000-00011","article-title":"Circulating tumor necrosis factor-alpha levels and lipid abnormalities in patients with cystic fibrosis","volume":"34","author":"Levy","year":"1993","journal-title":"Pediatr Res"},{"issue":"8","key":"10.1016\/j.jcf.2019.08.016_bb0215","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1210\/jc.2015-1512","article-title":"Age- and sex-dependent distribution of OGTT-related variables in a population of cystic fibrosis patients","volume":"100","author":"Battezzati","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.jcf.2019.08.016_bb0220","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/BF00400362","article-title":"Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects","volume":"36","author":"Horowitz","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcf.2019.08.016_bb0225","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/164_2015_9","article-title":"Incretins","volume":"233","author":"Wu","year":"2015","journal-title":"Handb Exp Pharmacol"},{"issue":"5","key":"10.1016\/j.jcf.2019.08.016_bb0230","doi-asserted-by":"crossref","first-page":"E851","DOI":"10.1210\/jc.2010-2460","article-title":"Gastric emptying, incretin hormone secretion, and postprandial glycemia in cystic fibrosis-effects of pancreatic enzyme supplementation","volume":"96","author":"Kuo","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jcf.2019.08.016_bb0235","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1515\/JPEM.1994.7.1.13","article-title":"First-phase insulin response to intravenous glucose in cystic fibrosis patients with different degrees of glucose tolerance","volume":"7","author":"Cucinotta","year":"1994","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.016_bb0240","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/dom.13544","article-title":"Exenatide corrects postprandial hyperglycaemia in young people with cystic fibrosis and impaired glucose tolerance: a randomized crossover trial","volume":"21","author":"Geyer","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jcf.2019.08.016_bb0245","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","article-title":"Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American diabetes association and a clinical practice guideline of the cystic fibrosis foundation, endorsed by the pediatric endocrine society","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcf.2019.08.016_bb0250","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/pedi.12732","article-title":"ISPAD clinical practice consensus guidelines 2018: management of cystic fibrosis-related diabetes in children and adolescents","volume":"Suppl 27","author":"Moran","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jcf.2019.08.016_bb0255","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jcf.2007.02.005","article-title":"Increased glucose excursion in cystic fibrosis and its association with a worse clinical status","volume":"6","author":"Costa","year":"2007","journal-title":"J Cyst Fibros"},{"issue":"7","key":"10.1016\/j.jcf.2019.08.016_bb0260","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.2337\/dc17-2419","article-title":"Hemoglobin A1c accurately predicts continuous glucose monitoring-derived average glucose in youth and young adults with cystic fibrosis","volume":"41","author":"Chan","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcf.2019.08.016_bb0265","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jcf.2016.02.005","article-title":"Glycated hemoglobin cannot yet be proposed as a screening tool for cystic fibrosis related diabetes","volume":"15","author":"Boudreau","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2019.08.016_bb0270","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jcf.2015.03.013","article-title":"HbA1c as a screening tool for cystic fibrosis related diabetes","volume":"15","author":"Burgess","year":"2016","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.jcf.2019.08.016_bb0275","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2337\/dc08-1925","article-title":"Validation of continuous glucose monitoring in children and adolescents with cystic fibrosis","volume":"32","author":"O'Riordan","year":"2009","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.jcf.2019.08.016_bb0280","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.2337\/diacare.26.6.1940-a","article-title":"Validation of interstitial fluid continuous glucose monitoring in cystic fibrosis [2]","volume":"26","author":"Dobson","year":"2003","journal-title":"Diabetes Care"},{"issue":"3 Pt 1","key":"10.1016\/j.jcf.2019.08.016_bb0285","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1262-3636(07)70189-1","article-title":"Diabetes: a major co-morbidity of cystic fibrosis","volume":"31","author":"Costa","year":"2005","journal-title":"Diabetes Metab"},{"issue":"1","key":"10.1016\/j.jcf.2019.08.016_bb0290","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jcf.2017.05.010","article-title":"The use of fructosamine in cystic fibrosis-related diabetes (CFRD) screening","volume":"17","author":"Lam","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2019.08.016_bb0295","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4158\/EP09149.OR","article-title":"Lack of correlation between 1,5-anhydroglucitol assay and oral glucose tolerance test in patients with cystic fibrosis","volume":"16","author":"Kinnaird","year":"2010","journal-title":"Endocr Pract"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.016_bb0300","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2337\/dc10-1604","article-title":"Elevation of 1-hour plasma glucose during oral glucose tolerance testing is associated with worse pulmonary function in cystic fibrosis","volume":"34","author":"Brodsky","year":"2011","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.016_bb0305","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0022-3476(88)80315-9","article-title":"Diabetes mellitus associated with cystic fibrosis","volume":"112","author":"Finkelstein","year":"1988","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2019.08.016_bb0310","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/BF01957574","article-title":"Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis","volume":"151","author":"Lanng","year":"1992","journal-title":"Eur J Pediatr"},{"issue":"4","key":"10.1016\/j.jcf.2019.08.016_bb0315","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/MED.0b013e32833a780d","article-title":"Recent trends in cystic fibrosis-related diabetes","volume":"17","author":"Nathan","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.jcf.2019.08.016_bb0320","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jcf.2006.03.009","article-title":"Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis","volume":"6","author":"Brennan","year":"2007","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2019.08.016_bb0325","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.2337\/diacare.28.9.2141","article-title":"Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis","volume":"28","author":"Milla","year":"2005","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.jcf.2019.08.016_bb0330","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.2337\/dc06-1576","article-title":"Microvascular complications in cystic fibrosis-related diabetes","volume":"30","author":"Schwarzenberg","year":"2007","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.jcf.2019.08.016_bb0335","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jcf.2008.05.008","article-title":"Microvascular complications in patients with cystic fibrosis-related diabetes (CFRD)","volume":"7","author":"van den Berg","year":"2008","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.016_bb0340","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jcf.2014.07.014","article-title":"Retinal screening of patients with cystic fibrosis-related diabetes in Wales-a real eye opener","volume":"14","author":"Roberts","year":"2015","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.jcf.2019.08.016_bb0345","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/ajcn\/75.6.1005","article-title":"Abnormal lipid concentrations in cystic fibrosis","volume":"75","author":"Figueroa","year":"2002","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.016_bb0350","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jcf.2012.08.012","article-title":"Hypertriglyceridemia is associated with insulin levels in adult cystic fibrosis patients","volume":"12","author":"Ishimo","year":"2013","journal-title":"J Cyst Fibros"},{"issue":"Suppl. 1","key":"10.1016\/j.jcf.2019.08.016_bb0355","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1258\/jrsm.2010.s11010","article-title":"Ischaemic heart disease\u2014a new issue in cystic fibrosis?","volume":"103","author":"Perrin","year":"2010","journal-title":"J R Soc Med"},{"key":"10.1016\/j.jcf.2019.08.016_bb0360","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2466-6-9","article-title":"An adult cystic fibrosis patient presenting with persistent dyspnea: case report","volume":"6","author":"Onady","year":"2006","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jcf.2019.08.016_bb0365","first-page":"42","article-title":"Diabetes care","author":"Standards of medical care in diabetes 2019","year":"2019","journal-title":"Am Diabetes Assoc"},{"key":"10.1016\/j.jcf.2019.08.016_bb0370","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jcf.2013.06.001","article-title":"Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test","volume":"13","author":"Schmid","year":"2014","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2019.08.016_bb0375","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jcf.2013.11.005","article-title":"Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients","volume":"13","author":"Leclercq","year":"2014","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2019.08.016_bb0380","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00592-015-0791-3","article-title":"The 1-h oral glucose tolerance test glucose and insulin values are associated with markers of clinical deterioration in cystic fibrosis","volume":"53","author":"Coriati","year":"2016","journal-title":"Acta Diabetol"},{"issue":"10","key":"10.1016\/j.jcf.2019.08.016_bb0385","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ppul.23237","article-title":"Elevation of one hour plasma glucose during oral glucose tolerance testing","volume":"50","author":"Sheikh","year":"2015","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"10.1016\/j.jcf.2019.08.016_bb0390","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jcf.2018.03.009","article-title":"Prevalence of hypoglycemia during oral glucose tolerance testing in adults with cystic fibrosis and risk of developing cystic fibrosis-related diabetes","volume":"17","author":"Mannik","year":"2018","journal-title":"J Cyst Fibros"},{"issue":"S2","key":"10.1016\/j.jcf.2019.08.016_bb01350","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jcf.2019.08.025","article-title":"Continuous glucose monitoring in cystic fibrosis - A practical guide","volume":"18","author":"Chan","year":"2019","journal-title":"J Cyst Fibros"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199319308707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199319308707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:42:07Z","timestamp":1761601327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199319308707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":79,"alternative-id":["S1569199319308707"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2019.08.016","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cystic fibrosis related diabetes: Pathophysiology, screening and diagnosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2019.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}